Medacta Group SA

SIX:MOVE.SW

112.6 (CHF) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 288.649255.637255.141225.851211.271185.638177.488167.684134.808158.985151.638139.339133.27168.15361.17161.17161.17154.76354.76354.763
Cost of Revenue 90.91183.65679.27568.98562.88153.02848.85147.37440.86246.86740.05935.04233.58817.15815.5215.5215.5213.62513.62513.625
Gross Profit 197.738171.981175.866156.866148.39132.61128.637120.3193.946112.118111.579104.29799.68350.99545.65145.65145.65141.13841.13841.138
Gross Profit Ratio 0.6850.6730.6890.6950.7020.7140.7250.7170.6970.7050.7360.7490.7480.7480.7460.7460.7460.7510.7510.751
Reseach & Development Expenses 10.27110.7289.598.4987.7256.7564.553.5643.2654.1393.5021.7022.2310.9830.8690.8690.8690.7780.7780.778
General & Administrative Expenses 36.52931.83133.9730.85129.7724.94724.88422.422.81229.17420.1116.99116.6192.8132.752.752.753.0313.0313.031
Selling & Marketing Expenses 105.66897.21489.45782.49877.09671.57460.98155.66554.40470.82256.26553.72251.23526.23924.35924.35924.35921.44321.44321.443
SG&A 142.197129.045123.427113.349106.86696.52185.86578.06577.21699.99676.37570.71367.85429.05227.10927.10927.10924.47424.47424.474
Other Expenses 2.420.720000000008.688-29.859-29.859-27.72-27.72-27.72-24.932-24.932-24.932
Operating Expenses 154.888140.493132.911131.185115.964105.62897.05890.59480.83112.48294.2774.85569.2010.1760.2580.2580.2580.320.320.32
Operating Income 42.8531.48843.29135.73633.72129.01738.06439.54713.2967.87132.22431.2130.48215.03512.25912.25912.25912.45312.45312.453
Operating Income Ratio 0.1480.1230.170.1580.160.1560.2140.2360.0990.050.2130.2240.2290.2210.20.20.20.2270.2270.227
Total Other Income Expenses Net 1.814-8.962-7.091-11.486-3.179-5.155-6.475-8.89-4.021-7.643-18.82-3.434-0.218-0.525-0.422-0.422-0.422-0.298-0.298-0.298
Income Before Tax 44.66422.52636.224.2530.54223.86231.58930.6579.2750.22813.40427.77630.26414.5111.83811.83811.83812.15512.15512.155
Income Before Tax Ratio 0.1550.0880.1420.1070.1450.1290.1780.1830.0690.0010.0880.1990.2270.2130.1940.1940.1940.2220.2220.222
Income Tax Expense 6.6724.3077.0573.6274.9162.0791.8513.250.4090.3352.1086.2326.0553.0723.4643.4643.4642.352.352.35
Net Income 37.99218.21929.14320.62325.62621.78329.73827.4079.6840.56311.29621.54424.20911.4388.3748.3748.3749.8059.8059.805
Net Income Ratio 0.1320.0710.1140.0910.1210.1170.1680.1630.0720.0040.0740.1550.1820.1680.1370.1370.1370.1790.1790.179
EPS 1.90.911.461.031.281.091.491.370.480.0280.560.54604.980.570.420.420.420.490.490.49
EPS Diluted 1.90.911.461.031.281.091.491.370.480.0280.560.54604.980.570.420.420.420.490.490.49
EBITDA 77.52448.22471.4248.90358.05441.23356.58249.90432.05218.09448.40441.88542.83221.24517.85617.85617.85617.13317.13317.133
EBITDA Ratio 0.2690.1890.280.2170.2750.2220.3190.2980.2380.1140.3190.3010.3210.3120.2920.2920.2920.3130.3130.313